Release Date: 19/11/12 20:05 Summary: Response to ASX Price Query Price Sensitive: Yes Download Document 161.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%